Cutler Group LP Geron Corp Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	SELL	$1.74 - $2.31 $348 - $462	-200 Reduced 66.67%	100 $0
Q2 2023 Jul 18, 2023	BUY	$1.97 - $3.69 $394 - $738	200 Added 200.0%	300 $0
Q1 2023 May 01, 2023	BUY	$2.14 - $3.4 $214 - $340	100 New	100 $0
Q1 2021 Apr 26, 2021	SELL	$1.52 - $2.1 $35,416 - $48,930	-23,300 Reduced 99.57%	100 $0
Q3 2018 Nov 07, 2018	BUY	$1.76 - $6.38 $41,184 - $149,292	23,400 New	23,400 $103,000

276

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.08B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.